Title: Dyslipidemia Management in Women and Men: Exploring Potential Gender Differences
Abstract: Dyslipidemia is a treatable risk factor for coronary heart disease (CHD). Although lowering low-density lipoprotein cholesterol (LDL-C) is the primary goal set by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III), data indicates that in women high-density lipoprotein cholesterol (HDL-C) and non-HDL-C may better predict CHD risk. In addition, elevated triglycerides (TG) appear to be an independent risk factor for CHD, especially in women. Although men and women may differ slightly on the prognostic importance of certain lipid subfractions, current data indicates that standard treatment for dyslipidemia is equally effective in women as in men. Although more studies are needed to fully understand the differences and similarities of CHD in men versus women, it is important that proven data be utilized appropriately in clinical practice. Lipid-lowering medication should be used in both genders for both primary and secondary prevention of CHD.
Publication Year: 2004
Publication Date: 2004-01-01
Language: en
Type: book-chapter
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot